NASDAQ:NVNO | Free Cash Flow | enVVeno Medical Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.24M
2025-12-31-$3.44M$0.00-$3.44M
2025-03-31-$4.02M
2024-12-31-$5.11M$4,000.00-$5.11M
2024-03-31-$3.55M$10,000.00-$3.56M
2023-12-31-$4.97M$4,000.00-$4.98M
2023-03-31-$5.11M$5,000.00-$5.11M
2022-12-31-$3.86M$9,000.00-$3.87M
2022-03-31-$3.32M$69,000.00-$3.39M
2021-12-31-$3.1M$65,000.00-$3.17M
2021-03-31-$3.84M$24,000.00-$3.87M
2020-12-31-$2.61M$27,540.00-$2.64M
2020-03-31-$1.15M$5,313.00-$1.16M
2019-12-31-$1.62M$12,957.00-$1.64M
2019-03-31-$1.49M$1,800.00-$1.5M
2018-12-31-$1.44M$4,103.00-$1.45M
2018-03-31-$1.63M
2017-12-31-$1.27M$8,673.00-$1.28M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.57M$5,000.00-$15.57M
2024-12-31-$16.84M$37,000.00-$16.88M
2023-12-31-$18.86M$33,000.00-$18.89M
2022-12-31-$15.62M$115,000.00-$15.73M
2021-12-31-$11.85M$368,000.00-$12.22M
2020-12-31-$7.68M$180,291.00-$7.86M
2019-12-31-$5.9M$363,891.00-$6.26M
2018-12-31-$6.36M$12,422.00-$6.37M
2017-12-31-$4.2M$10,938.00-$4.21M